Search Results - Mithani, Runa

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial

    Safety, Tolerability, and Immunogenicity of an mRNA-Based Respiratory Syncytial Virus Vaccine in Healthy Young Adults in a Phase 1 Clinical Trial by Shaw, Christine A, Mithani, Runa, Kapoor, Archana, Dhar, Rakesh, Wilson, Lauren, El Asmar, Laila, Schnyder-Ghamloush, Sabine, Schaefers, Kristi, August, Allison, Stoszek, Sonia K, Chen, Grace L

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

    Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults by Shaw, Christine A, Essink, Brandon, Harper, Charles, Mithani, Runa, Kapoor, Archana, Dhar, Rakesh, Wilson, Lauren, Guo, Ruiting, Panozzo, Catherine A, Wilson, Eleanor, Simorellis, Alana K, Reuter, Caroline, Stoszek, Sonia K, Chen, Grace L, Das, Rituparna, Goswami, Jaya

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    2655. Phase 1 Safety and Immunogenicity Results of Two Investigational mRNA Vaccines, mRNA-1345, a Respiratory Syncytial Virus Vaccine, and mRNA-1653, a Human Metapneumovirus and Parainfluenza Virus Type 3 Combination Vaccine in Seropositive Young Children

    2655. Phase 1 Safety and Immunogenicity Results of Two Investigational mRNA Vaccines, mRNA-1345, a Respiratory Syncytial Virus Vaccine, and mRNA-1653, a Human Metapneumovirus and P... by Snape, Matthew D, Ghamloush, Sabine Schnyder, Chen, Grace L, Dhar, Rakesh, Mithani, Runa, Righi, Vinicius, Morsy, Louie, Kapoor, Archana, Girard, Bethany, Asmar, Laila El, Shaw, Christine A

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial

    234. Safety and Immunogenicity of mRNA-1345, an mRNA-Based RSV Vaccine in Younger and Older Adult Cohorts: Results from a Phase 1, Randomized Clinical Trial by Chen, Grace L, Mithani, Runa, Kapoor, Archana, Lu, Sophia, Asmar, Laila El, Panozzo, Catherine A, Shaw, Christine A, Stoszek, Sonia K, August, Allison

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial

    Safety and immunogenicity of an mRNA-based RSV vaccine in Japanese older adults aged ≥60 years: A phase 1, randomized, observer-blind, placebo-controlled trial by Fitz-Patrick, David, Mihara, Hanako, Mills, Anthony, Mithani, Runa, Kapoor, Archana, Dhar, Rakesh, Wilson, Lauren, Guo, Ruiting, Simorellis, Alana K., Panozzo, Catherine A., Reuter, Caroline, Wilson, Eleanor, Chen, Grace L., Stoszek, Sonia K., Shaw, Christine A., Goswami, Jaya

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:

Search Tools: